ScoreWhy is Shanghai Medicilon, Inc. ?
1
Poor Management Efficiency with a low ROCE of 14.86%
- The company has been able to generate a Return on Capital Employed (avg) of 14.86% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 10.23% and Operating profit at -197.62% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 11.56% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 10.23% and Operating profit at -197.62% over the last 5 years
4
With a growth in Net Profit of 130.46%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 176.6 MM
- ROCE(HY) Highest at -5.06%
- DEBTORS TURNOVER RATIO(HY) Highest at 2.48 times
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 51.31%, its profits have risen by 54.3%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shanghai Medicilon, Inc. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai Medicilon, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shanghai Medicilon, Inc.
51.31%
3.85
69.79%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.23%
EBIT Growth (5y)
-197.62%
EBIT to Interest (avg)
22.18
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.45
Tax Ratio
8.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.35%
ROE (avg)
11.56%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.84
EV to EBIT
-61.38
EV to EBITDA
-203.44
EV to Capital Employed
5.12
EV to Sales
7.42
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.34%
ROE (Latest)
-7.23%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend36What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 176.6 MM
ROCE(HY)
Highest at -5.06%
DEBTORS TURNOVER RATIO(HY)
Highest at 2.48 times
NET SALES(Q)
Highest at CNY 396.83 MM
RAW MATERIAL COST(Y)
Fallen by -96.04% (YoY
OPERATING PROFIT(Q)
Highest at CNY 72.46 MM
OPERATING PROFIT MARGIN(Q)
Highest at 18.26 %
PRE-TAX PROFIT(Q)
Highest at CNY 38.52 MM
NET PROFIT(Q)
Highest at CNY 36.68 MM
EPS(Q)
Highest at CNY 0.27
-3What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -7.88 %
Here's what is working for Shanghai Medicilon, Inc.
Operating Cash Flow
Highest at CNY 176.6 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 396.83 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 38.52 MM has Grown at 200.29%
over average net sales of the previous four periods of CNY -38.41 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 36.68 MM has Grown at 203.65%
over average net sales of the previous four periods of CNY -35.38 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debtors Turnover Ratio
Highest at 2.48 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
At CNY 396.83 MM has Grown at 25.92%
over average net sales of the previous four periods of CNY 315.15 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 72.46 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 18.26 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 38.52 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 36.68 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.27
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -96.04% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Shanghai Medicilon, Inc.
Debt-Equity Ratio
Highest at -7.88 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
